J4D Stock Overview
Operates as a consumer health company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Kenvue Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$20.57 |
| 52 Week High | US$23.50 |
| 52 Week Low | US$16.08 |
| Beta | 0 |
| 1 Month Change | 2.11% |
| 3 Month Change | -8.72% |
| 1 Year Change | 18.87% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.18% |
Recent News & Updates
Recent updates
Shareholder Returns
| J4D | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 5.2% | -2.9% | 3.0% |
| 1Y | 18.9% | -12.1% | 19.3% |
Return vs Industry: J4D exceeded the German Personal Products industry which returned -11.3% over the past year.
Return vs Market: J4D matched the German Market which returned 18.5% over the past year.
Price Volatility
| J4D volatility | |
|---|---|
| J4D Average Weekly Movement | 3.9% |
| Personal Products Industry Average Movement | 3.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: J4D has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: J4D's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2022 | 22,000 | Thibaut Mongon | www.kenvue.com |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Kenvue Inc. Fundamentals Summary
| J4D fundamental statistics | |
|---|---|
| Market cap | €40.22b |
| Earnings (TTM) | €985.20m |
| Revenue (TTM) | €14.78b |
40.8x
P/E Ratio2.7x
P/S RatioIs J4D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| J4D income statement (TTM) | |
|---|---|
| Revenue | US$15.46b |
| Cost of Revenue | US$6.40b |
| Gross Profit | US$9.06b |
| Other Expenses | US$8.03b |
| Earnings | US$1.03b |
Last Reported Earnings
Dec 29, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.54 |
| Gross Margin | 58.62% |
| Net Profit Margin | 6.66% |
| Debt/Equity Ratio | 82.9% |
How did J4D perform over the long term?
See historical performance and comparisonDividends
3.7%
Current Dividend Yield151%
Payout RatioDoes J4D pay a reliable dividends?
See J4D dividend history and benchmarks| Kenvue dividend dates | |
|---|---|
| Ex Dividend Date | Feb 12 2025 |
| Dividend Pay Date | Feb 26 2025 |
| Days until Ex dividend | 8 days |
| Days until Dividend pay date | 6 days |
Does J4D pay a reliable dividends?
See J4D dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/18 16:09 |
| End of Day Share Price | 2025/02/18 00:00 |
| Earnings | 2024/12/29 |
| Annual Earnings | 2024/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kenvue Inc. is covered by 21 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Lauren Lieberman | Barclays |
| Navann Ty Dietschi | BNP Paribas Exane |